What Verdica's 799 score means for ANTIBIOTICE
ANTIBIOTICE's composite score of 799 out of 850 places it in the "strong" band (740–799), reflecting a provider with consistent regulatory adherence and solid operational oversight. This score is built on data from state board of pharmacy records, FDA filings, and DEA compliance tracking—the core regulatory touchpoints that govern pharmaceutical manufacturers and distributors.
A score in this range suggests that ANTIBIOTICE meets baseline compliance requirements across multiple regulatory domains and has not triggered significant red flags in the underlying data. Readers should interpret this as a provider that has cleared standard hurdles: licensing is current, major infractions are absent or resolved, and quality documentation appears in order. However, the score is not perfect (which would be 850), meaning there are identifiable areas where performance falls short of the highest tier. This is typical and does not necessarily indicate risk—it often reflects routine compliance variances, administrative findings, or product-specific regulatory notes that regulators have documented but not escalated to enforcement action.
For a business owner or procurement team evaluating ANTIBIOTICE, a 799 score warrants confidence but not complacency. It signals a provider worth engaging, provided other factors (pricing, supply chain reliability, contract terms) align with your needs.
How the sub-scores break down
Product Approval (850): This perfect sub-score indicates that ANTIBIOTICE's registered pharmaceutical products have successfully cleared FDA approval pathways and maintain current status on approved drug lists. In pharmacy and manufacturing, product approval is non-negotiable; a score of 850 means every product in Verdica's indexed dataset has passed the required vetting and is legally marketable. This is the strongest signal of regulatory alignment.
Manufacturer Profile (720): This sub-score reflects the state and quality of ANTIBIOTICE's operational and facility data on record. A score of 720 suggests acceptable standing but with some documented gaps. These might include minor discrepancies in facility registration details, delayed renewal filings, or unresolved administrative notes from state pharmacy boards. In the pharmacy industry, a 720 on manufacturer profile typically indicates the entity is compliant but may have incurred low-severity citations or has incomplete documentation in one or more regulatory jurisdictions.
FDA Compliance (830): This high sub-score shows strong adherence to federal regulatory standards. ANTIBIOTICE does not carry major FDA enforcement actions, warning letters, or product recalls in the indexed data. An 830 score suggests the manufacturer has passed FDA facility inspections with minimal observations or has resolved prior findings to the agency's satisfaction. This is a strong indicator of quality control and process discipline.
What regulators track for pharmacy providers
State boards of pharmacy maintain licensing records, facility inspections, and enforcement histories for all registered manufacturers and distributors. They flag incomplete renewal applications, operational violations (such as improper storage or handling), and disciplinary actions. The FDA tracks product approvals, post-market safety reports, facility inspection results, and recalls. The DEA monitors controlled substance registration, supply chain records, and diversion risk. Together, these three data streams create a compliance profile. A provider's score improves with clean inspection histories, timely renewals, and absence of recalls or warning letters. It declines with unresolved citations, product suspensions, licensing lapses, or enforcement actions. Verdica's methodology weights these findings to produce a composite score that reflects overall regulatory standing.
Bottom line
ANTIBIOTICE presents as a strong, low-risk provider based on its 799 score, particularly given its perfect product approval rating and robust FDA compliance. Before contracting, verify current state pharmacy licenses, confirm product catalogs against FDA approval databases, and request recent facility inspection summaries to ensure the strong score reflects your specific use case.